跳到主要內容

Qiming Venture Partners VI, L.P. 的 Form 4 申報

Alamar Biosciences, Inc.ALMR,2026/10/27 申報

申報編號
0001231919-26-001501
申報時間
2026/10/27 16:10 ET
交易日
2026/10/23-10/26
申報延遲
4 天
10b5-1 計畫
沒有勾選

這份申報列了 20 筆非衍生性交易。公開市場賣出合計 $857.0 萬。交易後 4 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Qiming Venture Partners VI, L.P.CIK 0001733278持股 10% 以上大股東
Qiming Managing Directors Fund VI, L.P.CIK 0001733282持股 10% 以上大股東
Qiming Venture Partners VIII-HC, L.P.CIK 0001910025持股 10% 以上大股東
Qiming Corporate GP VI, Ltd.CIK 0002059127持股 10% 以上大股東
Qiming Venture Partners VIII Investments, LLCCIK 0002129618持股 10% 以上大股東
Qiming GP VIII-HC, LLCCIK 0002129671持股 10% 以上大股東
Qiming GP VIII, LLCCIK 0002129740持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/10/23Common StockS賣出處分−107$29.35F1−$3,140.45172,231間接
2026/10/23Common StockS賣出處分−832$30.23F3−$25,151.36171,399間接
2026/10/23Common StockS賣出處分−1,646$30.85F4−$50,779.1169,753間接
2026/10/23Common StockS賣出處分−3,975$29.35F1−$116,666.256,400,806間接
2026/10/23Common StockS賣出處分−30,921$30.23F3−$934,741.836,369,885間接
2026/10/23Common StockS賣出處分−61,191$30.85F4−$1,887,742.356,308,694間接
2026/10/23Common StockS賣出處分−928$29.35F1−$27,236.81,493,506間接
2026/10/23Common StockS賣出處分−7,215$30.23F3−$218,109.451,486,291間接
2026/10/23Common StockS賣出處分−14,277$30.85F4−$440,445.451,472,014間接
2026/10/23Common StockS賣出處分−1,110$29.35F1−$32,578.51,788,073間接
2026/10/23Common StockS賣出處分−8,638$30.23F3−$261,126.741,779,435間接
2026/10/23Common StockS賣出處分−17,094$30.85F4−$527,349.91,762,341間接
2026/10/26Common StockS賣出處分−2,313$30.52F8−$70,592.76167,440間接
2026/10/26Common StockS賣出處分−2$31.07F9−$62.14167,438間接
2026/10/26Common StockS賣出處分−86,008$30.52F8−$2,624,964.166,222,686間接
2026/10/26Common StockS賣出處分−70$31.07F9−$2,174.96,222,616間接
2026/10/26Common StockS賣出處分−20,069$30.52F8−$612,505.881,451,945間接
2026/10/26Common StockS賣出處分−16$31.07F9−$497.121,451,929間接
2026/10/26Common StockS賣出處分−24,027$30.52F8−$733,304.041,738,314間接
2026/10/26Common StockS賣出處分−19$31.07F9−$590.331,738,295間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.605 to $29.56, inclusive. The reporting person undertakes to provide to Alamar Biosciences, Inc., any security holder of Alamar Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes (1), (3), (4), (8) and (9) to this Form 4

表 I 有 4 筆交易的價格引用這則附註。

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.62 to $30.61, inclusive.

表 I 有 4 筆交易的價格引用這則附註。

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.62 to $31.335, inclusive.

表 I 有 4 筆交易的價格引用這則附註。

F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.07 to $31.065, inclusive.

表 I 有 4 筆交易的價格引用這則附註。

F9

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.07 to $31.115, inclusive.

表 I 有 4 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)